382 related articles for article (PubMed ID: 31740054)
21. Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation.
Rizk OH; Teleb M; Abu-Serie MM; Shaaban OG
Bioorg Chem; 2019 Nov; 92():103189. PubMed ID: 31473473
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
[TBL] [Abstract][Full Text] [Related]
23. The Effects of 1,3,5-trisubstituted Indole Derivatives on Cell Growth, Apoptosis and MMP-2/9 mRNA Expression of MCF-7 Human Breast Cancer Cells.
Bakar F; Kilic-Kurt Z; Caglayan MG; Olgen S
Anticancer Agents Med Chem; 2017; 17(5):762-767. PubMed ID: 27491936
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
[TBL] [Abstract][Full Text] [Related]
25. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
[TBL] [Abstract][Full Text] [Related]
26. Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-
Abd Al Moaty MN; El Ashry ESH; Awad LF; Ibrahim NA; Abu-Serie MM; Barakat A; Altowyan MS; Teleb M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458618
[TBL] [Abstract][Full Text] [Related]
27. Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor.
Senn N; Ott M; Lanz J; Riedl R
J Med Chem; 2017 Dec; 60(23):9585-9598. PubMed ID: 28953404
[TBL] [Abstract][Full Text] [Related]
28. Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(II) complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion.
Rahman FU; Ali A; Khan IU; Duong HQ; Guo R; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 Jan; 125():1064-1075. PubMed ID: 27810593
[TBL] [Abstract][Full Text] [Related]
29. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9.
Lobo G; Monasterios M; Rodrigues J; Gamboa N; Capparelli MV; Martínez-Cuevas J; Lein M; Jung K; Abramjuk C; Charris J
Eur J Med Chem; 2015; 96():281-95. PubMed ID: 25899333
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of 4-phenoxybenzenesulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Mao J; Zhang H; Wang X; Gao J; Tang J; Zhang J
Biosci Trends; 2020 Jul; 14(3):192-199. PubMed ID: 32389938
[TBL] [Abstract][Full Text] [Related]
32. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
Li W; Sun Q; Song L; Gao C; Liu F; Chen Y; Jiang Y
Eur J Med Chem; 2017 Dec; 141():721-733. PubMed ID: 29107429
[TBL] [Abstract][Full Text] [Related]
33. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
Mendes DE; Wong-On-Wing A; Berkman CE
J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
[TBL] [Abstract][Full Text] [Related]
34. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer and matrix metalloproteinases inhibitors of polyphenols from Selaginella tamariscina with suppression activity of migration.
Wang CG; Yao WN; Zhang B; Hua J; Liang D; Wang HS
Bioorg Med Chem Lett; 2018 Aug; 28(14):2413-2417. PubMed ID: 29921475
[TBL] [Abstract][Full Text] [Related]
36. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects.
Omar AM; Bajorath J; Ihmaid S; Mohamed HM; El-Agrody AM; Mora A; El-Araby ME; Ahmed HEA
Bioorg Chem; 2020 Aug; 101():103992. PubMed ID: 32554279
[TBL] [Abstract][Full Text] [Related]
37. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
38. Nature-inspired new isoindole-based Passerini adducts as efficient tumor-selective apoptotic inducers via caspase-3/7 activation.
Ayoup MS; Mansour AF; Abdel-Hamid H; Abu-Serie MM; Mohyeldin SM; Teleb M
Eur J Med Chem; 2023 Jan; 245(Pt 1):114865. PubMed ID: 36335743
[TBL] [Abstract][Full Text] [Related]
39. Chemosensitization of non-small cell lung cancer to sorafenib via non-hydroxamate s-triazinedione-based MMP-9/10 inhibitors.
Khalil HH; El-Sheshtawy MM; Khattab SN; Abu-Serie MM; Shehat MG; Teleb M; Haiba NS
Bioorg Chem; 2024 Mar; 144():107155. PubMed ID: 38306827
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.
Kalva S; Agrawal N; Skelton AA; Saleena LM
Mol Biosyst; 2016 Jul; 12(8):2519-31. PubMed ID: 27250644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
